Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
140 participants
INTERVENTIONAL
2006-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Aerosolized Colistin to Mechanical Ventilated Patients With Pneumonia
NCT04633317
Effect of Additional Nebulized Amikacin in Ventilator-Associated Pneumonia Caused by Gram Negative Bacteria
NCT02574130
Bacterial Transmission Dynamics Study
NCT02401204
Gram-negative Bacilli and MRSA Screening in ICU in China
NCT04310722
0.12% Chlorhexidine Oral Care for the Prevention of Non-ventilator Hospital-acquired Pneumonia
NCT04403971
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
antibiotic
conventional antibiotics
antibiotics
conventional parenteral antibiotics
colistin group
nebulized colistin
nebulized colistin
nebulized colistin 75 mg every 12 hours
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
nebulized colistin
nebulized colistin 75 mg every 12 hours
antibiotics
conventional parenteral antibiotics
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* lactating woman
* colistin allergy
* severe renal impairment
* epilepsy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mahidol University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Siriraj Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Visanu Thamlikitkul, MD
Role: PRINCIPAL_INVESTIGATOR
Siriraj Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Siriraj Hospital
Bangkok, Bangkok, Thailand
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Siriraj CEU 50-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.